Court of Appeals for the D.C. Circuit April 27, 2018, Civil Action Nos. 17–2198 (JEB) (Ctr. for Responsible Sci. v. Gottlieb)

Also known as

United States · · · 27-04-2018

JAMES E. BOASBERG, United States District Judge

Plaintiffs-three individuals and the Center for Responsible Science-believe that everyone who participates in a clinical-drug trial should be aware of differences in the data between preclinical animal testing and clinical human-subject experimentation. To that end, in May 2014, they submitted a Citizen Petition to the Commissioner of the Food and Drug Administration requesting that three specific warnings be added to the standard informed-consent materials. When the FDA denied the Petition, Plaintiffs brought this one-count Administrative *7Procedure Act suit against the current Commissioner, Scott Gottlieb. Defendant now moves to dismiss, contending that none of the Plaintiffs has standing, thus robbing the Court of subject-matter jurisdiction. For the reasons discussed below, the Court agrees and will grant the Motion, but permit Plaintiffs an opportunity to amend.

I. Background

Few understand the long and arduous road a new drug takes to finally come to market. After the drug is developed, researchers often test its safety on laboratory animals in preclinical trials. See Compl., ¶¶ 91-92. If it can clear the preclinical stage, the drug sponsor submits an investigational new-drug application to the FDA, the agency responsible for regulating research on human subjects. Id., ¶¶ 88, 93. If approved, clinical research-i.e. , testing conducted on humans rather than animals-begins. As part of its duty to protect human subjects, the FDA requires the drug sponsor to obtain "legally effective informed consent" for each participant. See 21 C.F.R. § 50.20. Under current Agency regulations, informed-consent documents must contain eight elements, one of which describes "any reasonably foreseeable risks or discomforts to the subject." Id. § 50.25(a)(2).

It is on this last point that Plaintiffs believe the FDA is abdicating its duty.

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.